Loading...
Ambu A/S
AMBFF•PNK
Healthcare
Medical - Devices
$15.20
$0.00(0.00%)
Ambu A/S (AMBFF) Financial Performance & Income Statement Overview
Review Ambu A/S’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
12.90%
↑ 12.90%
Operating Income Growth
113.58%
↑ 113.58%
Net Income Growth
39.88%
↑ 39.88%
Operating Cash Flow Growth
56.95%
↑ 56.95%
Operating Margin
13.58%
↑ 13.58%
Gross Margin
60.27%
↑ 60.27%
Net Profit Margin
6.34%
↑ 6.34%
ROE
6.42%
↑ 6.42%
ROIC
12.35%
↑ 12.35%
Ambu A/S (AMBFF) Income Statement & Financial Overview
Review Ambu A/S's (AMBFF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.51B | $1.39B | $1.38B | $1.37B |
| Cost of Revenue | $585.00M | $570.00M | $551.00M | $554.00M |
| Gross Profit | $925.00M | $817.00M | $832.00M | $813.00M |
| Gross Profit Ratio | $0.61 | $0.59 | $0.60 | $0.59 |
| R&D Expenses | $79.00M | $86.00M | $84.00M | $81.00M |
| SG&A Expenses | $603.00M | $584.00M | $570.00M | $538.00M |
| Operating Expenses | $682.00M | $670.00M | $654.00M | $619.00M |
| Total Costs & Expenses | $1.27B | $1.24B | $1.21B | $1.17B |
| Interest Income | $4.00M | $6.00M | $3.00M | $4.00M |
| Interest Expense | $10.00M | $0.00 | $7.00M | $11.00M |
| Depreciation & Amortization | $88.00M | $88.00M | $89.00M | $91.00M |
| EBITDA | $335.00M | $248.00M | $270.00M | $285.00M |
| EBITDA Ratio | $0.22 | $0.18 | $0.20 | $0.21 |
| Operating Income | $243.00M | -$187.00M | $178.00M | $194.00M |
| Operating Income Ratio | $0.16 | -$0.13 | $0.13 | $0.14 |
| Other Income/Expenses (Net) | -$6.00M | $6.00M | -$4.00M | -$7.00M |
| Income Before Tax | $237.00M | -$181.00M | $174.00M | $187.00M |
| Income Before Tax Ratio | $0.16 | -$0.13 | $0.13 | $0.14 |
| Income Tax Expense | $54.00M | -$46.00M | $40.00M | $43.00M |
| Net Income | $183.00M | -$135.00M | $134.00M | $144.00M |
| Net Income Ratio | $0.12 | -$0.10 | $0.10 | $0.11 |
| EPS | $0.68 | -$0.51 | $0.50 | $0.54 |
| Diluted EPS | $0.68 | -$0.51 | $0.50 | $0.54 |
| Weighted Avg Shares Outstanding | $269.12M | $264.71M | $268.00M | $266.30M |
| Weighted Avg Shares Outstanding (Diluted) | $269.12M | $264.71M | $268.00M | $266.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan